Six-Month Response to Delamanid Treatment in MDR TB Patients
Delamanid, recently available for the treatment of multidrug-resistant tuberculosis (MDR TB), has had limited use outside clinical trials. We present the early treatment results for 53 patients from 7 countries who received a delamanid-containing treatment for MDR TB. Results show good tolerability...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Centers for Disease Control and Prevention
2017-10-01
|
| Series: | Emerging Infectious Diseases |
| Subjects: | |
| Online Access: | https://wwwnc.cdc.gov/eid/article/23/10/17-0468_article |
| _version_ | 1828487676498542592 |
|---|---|
| author | Cathy Hewison Gabriella Ferlazzo Zaza Avaliani Armen Hayrapetyan Sylvie Jonckheere Zarema Khaidarkhanova Erika Mohr Animesh Sinha Alena Skrahina Debrah Vambe Irina Vasilyeva Nathalie Lachenal Francis Varaine |
| author_facet | Cathy Hewison Gabriella Ferlazzo Zaza Avaliani Armen Hayrapetyan Sylvie Jonckheere Zarema Khaidarkhanova Erika Mohr Animesh Sinha Alena Skrahina Debrah Vambe Irina Vasilyeva Nathalie Lachenal Francis Varaine |
| author_sort | Cathy Hewison |
| collection | DOAJ |
| description | Delamanid, recently available for the treatment of multidrug-resistant tuberculosis (MDR TB), has had limited use outside clinical trials. We present the early treatment results for 53 patients from 7 countries who received a delamanid-containing treatment for MDR TB. Results show good tolerability and treatment response at 6 months. |
| first_indexed | 2024-12-11T09:54:49Z |
| format | Article |
| id | doaj.art-8fea9d157f5348aba9806729b1f2f174 |
| institution | Directory Open Access Journal |
| issn | 1080-6040 1080-6059 |
| language | English |
| last_indexed | 2024-12-11T09:54:49Z |
| publishDate | 2017-10-01 |
| publisher | Centers for Disease Control and Prevention |
| record_format | Article |
| series | Emerging Infectious Diseases |
| spelling | doaj.art-8fea9d157f5348aba9806729b1f2f1742022-12-22T01:12:17ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592017-10-0123101746174810.3201/eid2310.170468Six-Month Response to Delamanid Treatment in MDR TB PatientsCathy HewisonGabriella FerlazzoZaza AvalianiArmen HayrapetyanSylvie JonckheereZarema KhaidarkhanovaErika MohrAnimesh SinhaAlena SkrahinaDebrah VambeIrina VasilyevaNathalie LachenalFrancis VaraineDelamanid, recently available for the treatment of multidrug-resistant tuberculosis (MDR TB), has had limited use outside clinical trials. We present the early treatment results for 53 patients from 7 countries who received a delamanid-containing treatment for MDR TB. Results show good tolerability and treatment response at 6 months.https://wwwnc.cdc.gov/eid/article/23/10/17-0468_articleTuberculosismultidrug resistancedelamaniddrug therapycombinationantitubercular agents |
| spellingShingle | Cathy Hewison Gabriella Ferlazzo Zaza Avaliani Armen Hayrapetyan Sylvie Jonckheere Zarema Khaidarkhanova Erika Mohr Animesh Sinha Alena Skrahina Debrah Vambe Irina Vasilyeva Nathalie Lachenal Francis Varaine Six-Month Response to Delamanid Treatment in MDR TB Patients Emerging Infectious Diseases Tuberculosis multidrug resistance delamanid drug therapy combination antitubercular agents |
| title | Six-Month Response to Delamanid Treatment in MDR TB Patients |
| title_full | Six-Month Response to Delamanid Treatment in MDR TB Patients |
| title_fullStr | Six-Month Response to Delamanid Treatment in MDR TB Patients |
| title_full_unstemmed | Six-Month Response to Delamanid Treatment in MDR TB Patients |
| title_short | Six-Month Response to Delamanid Treatment in MDR TB Patients |
| title_sort | six month response to delamanid treatment in mdr tb patients |
| topic | Tuberculosis multidrug resistance delamanid drug therapy combination antitubercular agents |
| url | https://wwwnc.cdc.gov/eid/article/23/10/17-0468_article |
| work_keys_str_mv | AT cathyhewison sixmonthresponsetodelamanidtreatmentinmdrtbpatients AT gabriellaferlazzo sixmonthresponsetodelamanidtreatmentinmdrtbpatients AT zazaavaliani sixmonthresponsetodelamanidtreatmentinmdrtbpatients AT armenhayrapetyan sixmonthresponsetodelamanidtreatmentinmdrtbpatients AT sylviejonckheere sixmonthresponsetodelamanidtreatmentinmdrtbpatients AT zaremakhaidarkhanova sixmonthresponsetodelamanidtreatmentinmdrtbpatients AT erikamohr sixmonthresponsetodelamanidtreatmentinmdrtbpatients AT animeshsinha sixmonthresponsetodelamanidtreatmentinmdrtbpatients AT alenaskrahina sixmonthresponsetodelamanidtreatmentinmdrtbpatients AT debrahvambe sixmonthresponsetodelamanidtreatmentinmdrtbpatients AT irinavasilyeva sixmonthresponsetodelamanidtreatmentinmdrtbpatients AT nathalielachenal sixmonthresponsetodelamanidtreatmentinmdrtbpatients AT francisvaraine sixmonthresponsetodelamanidtreatmentinmdrtbpatients |